The global histology and cytology market size was valued at USD 12.35 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.74% from 2021 to 2028. An increase in the demand for the detection of cell and tissue characteristics and a global increase in the prevalence of cell-based diseases, such as cancer, are major factors expected to drive the market throughout the forecast period. The integration of digital solutions to cytological diagnosis offers the advantage of the rapid interpretation of primary diagnostic data. In addition, companies are launching new and advanced digital cytology systems for assisting in the rapid on-site evaluation of cytology samples.
The In Vitro Diagnostic (IVD) labeled system will enable the diagnostic laboratories to maximize their sample throughput processing with an ideal turnaround time. The theCOVID-19 pandemic is acting as a positive catalyst for the growth of the market. The strategic collaboration is observed between the companies for developing antibodies specific for validation with immunohistochemistry. For instance, in September 2020, GeneTex, Inc. entered into a partnership with HistoWiz, Inc., for establishing various validated antibodies for immunohistochemistry in human COVID-19 infected tissues.
Key Player Mentioned:
To identify the key drivers and the competitors’ insights, Request a Sample @:
https://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market/request/rs1
Product Segment Analysis:
Application Segment Analysis:
The companies will also put collaborative efforts into developing an automated immunohistochemistry assay with GeneTex for detecting SARS-CoV-2 viral infection in different types of tissues. They also emphasized that IHC helps in the identification of the virus replication by the detection of viral proteins in infected tissues, unlike RT-PCR that only amplifies viral RNA fragments in the sample specimen.
Regional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa
Access Press Release: https://www.grandviewresearch.com/press-release/global-histology-cytology-market
The rise in the popularity of immunohistochemistry for visualizing cellular components to diagnose a wide range of diseases, such as cancers and other infectious diseases, is contributing to the growth of the market. Several companies are developing innovative immunohistochemistry instruments and reagents. For instance, in January 2021, Biocare Medical, LLC released ONCORE Pro, a completely automated staining platform for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) applications.
Why Purchase this Report?
About Us:
Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world’s renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide
Overview and Scope Nail care products refer to a variety of cosmetics and tools designed…
Overview and Scope Livestock identification refers to the process of uniquely identifying individual animals or…
Overview and Scope Healthcare gamification refers to the incorporation of game elements, such as competition,…
Overview and Scope Electronic design automation (EDA) refers to a category of software tools that…
Overview and Scope Medical image management encompasses the efficient handling and organization of diverse medical…
Overview and Scope Insolvency software refers to specialized tools and applications to assist businesses, financial…